Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 15:283:55-63.
doi: 10.1016/j.ijcard.2018.12.008. Epub 2018 Dec 4.

Anti-anginal drugs: Systematic review and clinical implications

Affiliations

Anti-anginal drugs: Systematic review and clinical implications

Rita Pavasini et al. Int J Cardiol. .

Erratum in

Abstract

Background: The cornerstone of the treatment of patients affected by stable angina is based on drugs administration classified as first (beta-blockers, calcium channel blockers, short acting nitrates) or second line treatment (long-acting nitrates, ivabradine, nicorandil, ranolazine and trimetazidine). However, few data on comparison between different classes of drugs justify that one class of drugs is superior to another.

Methods: We performed a systematic review of the literature following PRISMA guidelines.

Inclusion criteria: i) paper published in English; ii) diagnosis of stable coronary disease; iii) randomized clinical trial; iv) comparison of two anti-angina drugs; v) a sample size >100 patients; vi) a follow-up lasting at least 2 weeks; vii) paper published after 1999, when a meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina of Heidenreich et al. was published.

Outcome: to establish whether the categorization in first and second line antianginal treatment is scientifically supported.

Results: Eleven trials fulfilled inclusion criteria. The results show that there is a paucity of data comparing the efficacy of antianginal agents. The little data available show that there are not compounds superior to others in terms of improvement in exercise test duration, frequency of anginal attacks, need for sub-lingual nitroglycerin.

Conclusion: The categorization of antianginal drug in first and second line is not confirmed.

Keywords: Beta-blockers; Calcium channel blockers; Ivabradine; Ranolazine; Stable angina; Trimetazidine.

PubMed Disclaimer

Publication types

MeSH terms

Substances

LinkOut - more resources